NASDAQ:NMTC NeuroOne Medical Technologies (NMTC) Stock Price, News & Analysis $0.64 +0.02 (+3.40%) As of 05/13/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About NeuroOne Medical Technologies Stock (NASDAQ:NMTC) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get NMTC alerts:Sign Up Key Stats Today's Range$0.63▼$0.7150-Day Range$0.43▼$1.0852-Week Range$0.40▼$1.39Volume1.07 million shsAverage Volume183,180 shsMarket Capitalization$30.52 millionP/E RatioN/ADividend YieldN/APrice Target$1.45Consensus RatingBuy Company OverviewNeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.Read More… NeuroOne Medical Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks49th Percentile Overall ScoreNMTC MarketRank™: NeuroOne Medical Technologies scored higher than 49% of companies evaluated by MarketBeat, and ranked 584th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingNeuroOne Medical Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageNeuroOne Medical Technologies has only been the subject of 1 research reports in the past 90 days.Read more about NeuroOne Medical Technologies' stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of NeuroOne Medical Technologies is -2.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeuroOne Medical Technologies is -2.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNeuroOne Medical Technologies has a P/B Ratio of 6.44. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.97% of the float of NeuroOne Medical Technologies has been sold short.Short Interest Ratio / Days to CoverNeuroOne Medical Technologies has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeuroOne Medical Technologies has recently decreased by 3.98%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldNeuroOne Medical Technologies does not currently pay a dividend.Dividend GrowthNeuroOne Medical Technologies does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.97% of the float of NeuroOne Medical Technologies has been sold short.Short Interest Ratio / Days to CoverNeuroOne Medical Technologies has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeuroOne Medical Technologies has recently decreased by 3.98%, indicating that investor sentiment is improving. News and Social Media2.4 / 5News Sentiment0.29 News SentimentNeuroOne Medical Technologies has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.82 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for NeuroOne Medical Technologies this week, compared to 1 article on an average week.Search Interest2 people have searched for NMTC on MarketBeat in the last 30 days. MarketBeat FollowsOnly 3 people have added NeuroOne Medical Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -25% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, NeuroOne Medical Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $150,000.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 8.90% of the stock of NeuroOne Medical Technologies is held by insiders.Percentage Held by InstitutionsOnly 16.07% of the stock of NeuroOne Medical Technologies is held by institutions.Read more about NeuroOne Medical Technologies' insider trading history. Receive NMTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address NMTC Stock News HeadlinesNeuroOne Medical Technologies Corp (NMTC) Q2 2025 Earnings Call Highlights: Revenue Surge and ...May 14 at 3:40 AM | uk.finance.yahoo.comNeuroOne expects FY25 revenue to reach $8M–$10M as OneRF platform advances and new FDA submission broadens pipelineMay 13 at 5:37 PM | msn.comThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.May 14, 2025 | Crypto Swap Profits (Ad)NeuroOne Medical Technologies Corporation (NMTC) Q2 2025 Earnings Call TranscriptMay 13 at 10:14 AM | seekingalpha.comNeuroOne® Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6%May 13 at 7:30 AM | globenewswire.comNeuroOne Medical Technologies Corporation: NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical AdvisorMay 12 at 2:48 PM | finanznachrichten.deNeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical AdvisorMay 12 at 8:30 AM | globenewswire.comLadenburg Thalmann Initiates Coverage of NeuroOne Medical Technologies (NMTC) with Buy RecommendationMay 6, 2025 | msn.comSee More Headlines NMTC Stock Analysis - Frequently Asked Questions How have NMTC shares performed this year? NeuroOne Medical Technologies' stock was trading at $0.8259 at the start of the year. Since then, NMTC stock has decreased by 22.0% and is now trading at $0.6440. View the best growth stocks for 2025 here. How were NeuroOne Medical Technologies' earnings last quarter? NeuroOne Medical Technologies Co. (NASDAQ:NMTC) released its quarterly earnings data on Wednesday, February, 12th. The company reported $0.06 earnings per share (EPS) for the quarter. NeuroOne Medical Technologies had a negative net margin of 82.17% and a negative trailing twelve-month return on equity of 270.70%. Read the conference call transcript. Who are NeuroOne Medical Technologies' major shareholders? NeuroOne Medical Technologies' top institutional investors include Cambridge Investment Research Advisors Inc. (0.17%). Insiders that own company stock include Ronald W Mcclurg, Mark Christianson and Christopher Volker. View institutional ownership trends. How do I buy shares of NeuroOne Medical Technologies? Shares of NMTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of NeuroOne Medical Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that NeuroOne Medical Technologies investors own include Schwab US Large-Cap ETF (SCHX), NVIDIA (NVDA), Advanced Micro Devices (AMD), NIO (NIO), Ford Motor (F), Meta Platforms (META) and Plug Power (PLUG). Company Calendar Last Earnings2/12/2025Today5/14/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:NMTC CIK1500198 Webwww.originalsourcemusic.com Phone(952) 426-1383FaxN/AEmployees20Year FoundedN/APrice Target and Rating Average Stock Price Target$1.45 High Stock Price Target$1.45 Low Stock Price Target$1.45 Potential Upside/Downside+125.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-12,320,000.00 Net Margins-82.17% Pretax Margin-82.16% Return on Equity-270.70% Return on Assets-129.70% Debt Debt-to-Equity RatioN/A Current Ratio3.64 Quick Ratio2.41 Sales & Book Value Annual Sales$5.75 million Price / Sales5.31 Cash FlowN/A Price / Cash FlowN/A Book Value$0.10 per share Price / Book6.44Miscellaneous Outstanding Shares47,386,000Free Float28,116,000Market Cap$30.52 million OptionableOptionable Beta0.65 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (NASDAQ:NMTC) was last updated on 5/14/2025 by MarketBeat.com Staff From Our PartnersAI Boom Takes a Shocking Turn…The AI “Gold Rush” is Here… History's repeating itself — but this time, the shovels are digital. Crypto 101 Media | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Musk’s Next Big BetCancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredTrump’s betrayal exposed Trump’s third-term comments grabbed headlines, but the bigger story is what he’s planning next. A new report ...Porter & Company | SponsoredSilver Demand Is Soaring-Supply Can't Keep UpSilver demand hit 1.16 billion ounces in 2024-while supply fell short again for the fourth year in a row. I...i2i Marketing Group, LLC | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.